189350-34-3

Upstream product

• 501-53-1 benzyl chloroformate 
• 189350-32-1 (2R,3S)-1-tert-butyldiphenylsilyloxy-2-N-methylamino-3,4-O-methylethylidene-butan-3,4-diol 
• 189350-31-0 (2S,3R)-3-N-methylamino-1,2-O-methylethylidene-butan-1,2,4-triol 
• 114184-94-0 ethyl (R)-2-[(4'R)-2',2'-dimethyl-1,3-dioxolan-4'-yl]-2-hydroxyacetate 
• 189350-30-9 ethyl (2S,3S)-2-N-methylamino-3,4-O-methylethylidene-3,4-dihydroxybutanoate 

Downstream Products

• 189350-38-7 (2R,3S)-1-tert-butyldiphenylsilyloxy-2-N-methylbenzyloxycarbonylamino-3,4-epoxy-butane 
• 189350-36-5 (2R,3S)-1-tert-butyldiphenylsilyloxy-2-N-methylbenzyloxycarbonylaminobutan-3,4-diol 

Relevant academic research and scientific papers

On the way to liposidomycins, new nucleoside antibiotics. Access to the homochiral diazepanone core

Access to the homochiral diazepanone core of liposidomycins has been carried out through the regiospecific nucleophilic opening of an enantiomerically pure α-amino-β,γ-epoxy-acid precursor, by an L-amino acid derivative, on one hand and cyclisation by a p